Hypophosphataemia risk associated with ferric carboxymaltose in heart failure: A pooled analysis of clinical trials

AIMS: Iron deficiency is a common finding among patients with heart failure (HF) and is associated with adverse outcomes, including decreased quality of life, increased risk of hospitalization, and decreased survival. Intravenous ferric carboxymaltose (FCM) has been shown to improve outcomes among p...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosano, Giuseppe MC, Kalantar‐Zadeh, Kamyar, Jankowska, Ewa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053364/
https://www.ncbi.nlm.nih.gov/pubmed/36722321
http://dx.doi.org/10.1002/ehf2.14286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053364/
https://www.ncbi.nlm.nih.gov/pubmed/36722321
http://dx.doi.org/10.1002/ehf2.14286

Ejemplares similares